Clinical trial
Safety and Efficacy Study of Rituximab in Renal Transplantation
NCT00255593 · Karolinska University Hospital, Other · Completed
Key facts
| NCT number | NCT00255593 |
|---|---|
| Title | Safety and Efficacy Study of Rituximab in Renal Transplantation |
| Official title | A Prospective, Randomised, Placebo Controlled, Multicenter Study of the Efficacy and Safety of Rituximab as Induction Therapy Together With Tacrolimus, Mycophenolate Mofetil and Steroids for Patients Undergoing Renal Transplantation |
| Lead sponsor | Karolinska University Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | rituximab |
| Enrollment | 140 |
| Start date | Nov 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Nov 30, 2007 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: